TMEM130

Across TCGA pan-cancer cohorts, TMEM130 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated TMEM130 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher TMEM130 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TMEM130 expression acts as an unfavorable survival marker.

LUSC, LIHC, and SKCM are the cancer types where TMEM130 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.184	0.729	.001	21	view →
LIHC	OS	Median	All	0.061	0.777	<.001	12	view →
SKCM	OS	Median	All	0.596	0.786	.028	6	view →
LUAD	OS	Median	All	0.439	0.790	.043	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

TMEM130–LUSC (OS)

Open the LUSC breakdown →